• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

剂量增加对癫痫患者血清卡马西平浓度的影响。

Effect of dose increments on serum carbamazepine concentration in epileptic patients.

作者信息

Perucca E, Bittencourt P, Richens A

出版信息

Clin Pharmacokinet. 1980 Nov-Dec;5(6):576-82. doi: 10.2165/00003088-198005060-00006.

DOI:10.2165/00003088-198005060-00006
PMID:7438655
Abstract

The effect of progressive dose increments on the steady-state serum concentration of carbamazepine has been investigated prospectively in 20 adult institutionalised epileptic patients receiving long term therapy with the drug. In all but 1 subject, a strong positive correlation between the serum carbamazepine concentration and the prescribed daily dose was found. The relationship appeared to be linear over the dosage range examined (600 to 1400mg in most patients). In some patients, a trend was observed for the extrapolated regression lines to yield positive y-axis intercepts. The latter were significantly different from zero in 3 patients. Although these findings suggest that the relationship between serum carbamazepine concentration and dose may be curvilinear over the lower range of doses, further studies are required to clarify this point.

摘要

前瞻性地研究了递增剂量对20例接受卡马西平长期治疗的成年住院癫痫患者稳态血清浓度的影响。除1例患者外,其余患者血清卡马西平浓度与规定日剂量之间均呈强正相关。在所研究的剂量范围内(大多数患者为600至1400mg),这种关系似乎呈线性。在一些患者中,观察到外推回归线有产生正y轴截距的趋势。其中3例患者的y轴截距显著不同于零。尽管这些发现表明,在较低剂量范围内,血清卡马西平浓度与剂量之间的关系可能是曲线关系,但仍需要进一步研究来阐明这一点。

相似文献

1
Effect of dose increments on serum carbamazepine concentration in epileptic patients.剂量增加对癫痫患者血清卡马西平浓度的影响。
Clin Pharmacokinet. 1980 Nov-Dec;5(6):576-82. doi: 10.2165/00003088-198005060-00006.
2
Steady-state carbamazepine plasma concentration-dose ratios in epileptic patients.癫痫患者中卡马西平的稳态血药浓度与剂量比值
Clin Pharmacokinet. 1986 Sep-Oct;11(5):411-4. doi: 10.2165/00003088-198611050-00006.
3
Once daily dosage versus divided daily doses of carbamazepine therapy in epileptic patients: a pilot study.
Pharmatherapeutica. 1981;3(1):71-8.
4
[Serum levels of vitamin B12 in epileptic patients treated with carbamazepine].[卡马西平治疗癫痫患者的血清维生素B12水平]
Neurol Neurochir Pol. 1993 Sep-Oct;27(5):671-5.
5
Dose-dependency of the ratio between carbamazepine serum level and dosage in patients with epilepsy.
Ther Drug Monit. 1981;3(3):271-4. doi: 10.1097/00007691-198103000-00007.
6
[Carbamazepine dosage and its blood serum level in children].[儿童卡马西平的剂量及其血清水平]
Neurol Neurochir Pol. 1987 Jan-Feb;21(1):6-10.
7
The concentration of carbamazepine (Tegretol R) in serum and in cerebrospinal fluid in patients with epilepsy.癫痫患者血清和脑脊液中卡马西平(得理多)的浓度。
Acta Neurol Scand Suppl. 1972;51:445-6.
8
Chronotherapeutic dose schedule of phenytoin and carbamazepine in epileptic patients.癫痫患者苯妥英钠和卡马西平的时辰治疗剂量方案。
Chronobiol Int. 2006;23(5):1035-46. doi: 10.1080/07420520600921112.
9
Implications of metabolic parameters of carbamazepine in the therapeutic monitoring of Tunisian patients with epilepsy.卡马西平代谢参数在突尼斯癫痫患者治疗监测中的意义。
Rev Neurol (Paris). 2016 Apr-May;172(4-5):313-7. doi: 10.1016/j.neurol.2015.12.010. Epub 2016 Apr 6.
10
Carbamazepine drug interactions: the influence of concurrent drug therapy on serum concentrations of carbamazepine and its epoxide metabolite.卡马西平的药物相互作用:联合药物治疗对卡马西平及其环氧化物代谢物血清浓度的影响。
Zhonghua Yi Xue Za Zhi (Taipei). 1990 Apr;45(4):222-32.

引用本文的文献

1
Free concentration of carbamazepine and carbamazepine-10,11-epoxide in children and adults. Influence of age and phenobarbitone co-medication.儿童和成人中卡马西平和卡马西平-10,11-环氧化物的游离浓度。年龄和苯巴比妥联合用药的影响。
Clin Pharmacokinet. 1985 Nov-Dec;10(6):524-31. doi: 10.2165/00003088-198510060-00005.
2
Free drug concentration monitoring in clinical practice. Rationale and current status.临床实践中的游离药物浓度监测。原理与现状。
Clin Pharmacokinet. 1986 Nov-Dec;11(6):450-69. doi: 10.2165/00003088-198611060-00003.
3
Clinical pharmacokinetics and pharmacological effects of carbamazepine and carbamazepine-10,11-epoxide. An update.
卡马西平和卡马西平 - 10,11 - 环氧化物的临床药代动力学及药理作用。最新进展。
Clin Pharmacokinet. 1986 May-Jun;11(3):177-98. doi: 10.2165/00003088-198611030-00001.
4
Carbamazepine clearance in paediatric epilepsy patients. Influence of body mass, dose, sex and co-medication.
Clin Pharmacokinet. 1989 Sep;17(3):208-16. doi: 10.2165/00003088-198917030-00006.
5
Dose-dependent pharmacokinetics of carbamazepine in rats: determination of the formation clearance of carbamazepine-10,11-epoxide.
Pharm Res. 1990 May;7(5):513-7. doi: 10.1023/a:1015872901523.
6
Daily variations in steady-state plasma concentrations of carbamazepine and its metabolites in epileptic children.癫痫患儿中卡马西平及其代谢物稳态血浆浓度的每日变化。
Clin Pharmacokinet. 1991 Mar;20(3):237-46. doi: 10.2165/00003088-199120030-00005.
7
Autoinduction and steady-state pharmacokinetics of carbamazepine and its major metabolites.卡马西平及其主要代谢产物的自动诱导和稳态药代动力学
Br J Clin Pharmacol. 1992 Jun;33(6):611-5. doi: 10.1111/j.1365-2125.1992.tb04089.x.